Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
1:43
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Lymphoma Similar Videos
-
Virtual Challenging Case Clinic: B-cell Lymphomas - Follicular Lymphoma_Loretta Nastoupil, MD
51:37
-
Virtual Challenging Case Clinic: B-cell Lymphomas_Updates from ASH_Sonali Smith, MD, FASCO
50:40
-
IUCLS 2023 Saturday Afternoon General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS
3:34